⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 1, 2024Open Access

Table S2 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer

Minae An Arnav Mehta Byung‐Hoon Min You Jeong Heo Samuel J. Wright Milan Parikh Lynn Bi Hyuk Lee Tae Jun Kim Song-Yi Lee Jeonghyeon Moon Ryan J. Park Matthew R. Strickland Woong‐Yang Park Won Ki Kang Kyoung‐Mee Kim Seung Tae Kim Samuel J. Klempner Jeeyun Lee

View Full Paper

Ask AI

Bookmark

Share

Abstract

This is the authors' abstract. We don't add key points for this paper.

Adverse events on single arm sequential CAPOX and pembrolizumab in advanced gastric cancer.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

An et al. (2024) studied this question.

synapsesocial.com/papers/68e6c4b3b6db64358764357c https://doi.org/10.1158/2159-8290.25728951

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S2 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer2024
2Table S5 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer2024
3Table S5 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer2024
4Table S8 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer2024
5Table S8 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer2024

Table S3 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer2024
Table S3 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer2024
Figure S2 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer2024